tranexamic acid has been researched along with stanozolol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Basomba, A; Campos, A; García Villalmanzo, I; Guerrero, M; Peláez, A; Prieto, L | 1 |
| Agostoni, A; Castelli, R; Cicardi, M; Gardinali, M; Munari, M; Savi, C; Zingale, LC | 1 |
3 other study(ies) available for tranexamic acid and stanozolol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Familial angioedema (II). Treatment].
Topics: Aminocaproic Acid; Angioedema; Cinnarizine; Complement C1 Inactivator Proteins; Danazol; Histamine H1 Antagonists; Humans; Stanozolol; Tranexamic Acid | 1984 |
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency.
Topics: Aged; Anabolic Agents; Angioedema; Antifibrinolytic Agents; Aprotinin; Autoimmune Diseases; Calcium Channel Blockers; Cardiopulmonary Bypass; Complement Activation; Complement C1 Inactivator Proteins; Coronary Artery Bypass; Hemostatics; Heparin Antagonists; Humans; Laryngeal Edema; Male; Myocardial Infarction; Postoperative Complications; Protamines; Recurrence; Stanozolol; Tranexamic Acid | 1997 |